EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access · CC BY-NC 4.0

Clinical validation of two volumetric absorptive microsampling devices to support home‐based therapeutic drug monitoring of immunosuppression

Abbie D Leino iD, John Takyi-Williams iD, Jeong M Park iD, Silas P Norman iD, Duxin Sun iD, Karen B Farris iD, Manjunath P Pai iD

British Journal of Clinical Pharmacology · 2024

DOI: 10.1111/bcp.16182 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift British Journal of Clinical Pharmacology, 2024. Verfasst von Abbie D Leino und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, College of Pharmacy, University of Michigan, Ann Arbor, MI, USA. Hauptthemen laut MEDLINE: Drug Monitoring, Mycophenolic Acid, Immunosuppressive Agents, Kidney Transplantation. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: University of Michigan, College of Pharmacy, University of Michigan, Rackham Predoctoral Fellowship, College of Pharmacy, University of Michigan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Dried blood volumetric absorptive microsamples (VAMS) may facilitate home‐based sampling to enhance therapeutic drug monitoring after transplantation. This study aimed to clinically validate a liquid chromatography–tandem mass spectrometry assay using 2 VAMS devices with different sampling locations (Tasso‐M20 for the upper arm and Mitra for the finger). Patient preferences were also evaluated.

Methods

Clinical validation was performed for tacrolimus and mycophenolic acid by comparison of paired VAMS and venipuncture samples using Passing–Bablok regression and Bland–Altman analysis. Conversion of mycophenolic acid VAMS to serum concentrations was evaluated using haematocrit‐dependent formulas and fixed correction factors defined a priori. Patients' perspectives, including useability, acceptability and feasibility, were also investigated using established questionnaires.

Results

Paired samples ( n = 50) were collected from 25 kidney transplant recipients. Differences for tacrolimus whole‐blood concentration were within ±20% for 86 and 88% of samples from the upper arm and fingerstick, respectively. Using correction factors of 1.3 for the upper‐arm and 1.47 for finger‐prick samples, 84 and 76% of the paired samples, respectively, were within ±20% for mycophenolic acid serum concentration. Patient experience surveys demonstrated limited pain and acceptable useability of the upper‐arm device.

Conclusions

Tacrolimus and mycophenolic acid can be measured using 2 common VAMS devices with similar analytical performance. Patients are supportive of home‐based monitoring with a preference for the Tasso‐M20 device.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug MonitoringMycophenolic AcidImmunosuppressive AgentsKidney TransplantationTacrolimusDried Blood Spot TestingTandem Mass SpectrometryHumansMaleFemaleMiddle AgedAdultAgedChromatography, LiquidBlood Specimen CollectionPatient Preference

Stichwörter der Autor:innen

clinical validationimmunosuppressionvolumetric absorptive microsampling

Substanzen

Mycophenolic AcidImmunosuppressive AgentsTacrolimus

Autor:innen und Institutionen

  • Department of Clinical Pharmacy, College of Pharmacy, University of Michigan, Ann Arbor, MI, USA.
  • Pharmacokinetic & Mass Spectrometry Core, College of Pharmacy, University of Michigan, Ann Arbor, MI, USA.
  • Division of Nephrology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
  • Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, MI, USA.

ORCID-Profile: Abbie D Leino, John Takyi-Williams, Jeong M Park, Silas P Norman, Duxin Sun, Karen B Farris, Manjunath P Pai

Förderung

  • University of Michigan, College of Pharmacy
  • University of Michigan, Rackham Predoctoral Fellowship
  • College of Pharmacy, University of Michigan

Zitieren

APA

Leino, A. D., Takyi-Williams, J., Park, J. M., Norman, S. P., Sun, D., Farris, K. B., & Pai, M. P. (2024). Clinical validation of two volumetric absorptive microsampling devices to support home‐based therapeutic drug monitoring of immunosuppression. British Journal of Clinical Pharmacology. https://doi.org/10.1111/bcp.16182

Vancouver

Leino AD, Takyi-Williams J, Park JM, Norman SP, Sun D, Farris KB, et al. Clinical validation of two volumetric absorptive microsampling devices to support home‐based therapeutic drug monitoring of immunosuppression. British Journal of Clinical Pharmacology. 2024. doi:10.1111/bcp.16182

BibTeX
@article{Leino2024,
  author = {Leino, Abbie D and Takyi-Williams, John and Park, Jeong M and Norman, Silas P and Sun, Duxin and Farris, Karen B and Pai, Manjunath P},
  title = {Clinical validation of two volumetric absorptive microsampling devices to support home‐based therapeutic drug monitoring of immunosuppression},
  journal = {British Journal of Clinical Pharmacology},
  year = {2024},
  doi = {10.1111/bcp.16182}
}
Kostenlos starten →